Prospective evaluation of sequential treatment of sclerotic chronic graft versus host disease with rituximab and nilotinib
Sign Up to like & getrecommendations! Published in 2018 at "Bone Marrow Transplantation"
DOI: 10.1038/s41409-018-0158-9
Abstract: Sclerotic chronic graft vs. host disease (cGVHD) still has a large impact on morbidity and mortality after allogeneic hematopoietic stem cell transplantation (HSCT). We performed the first prospective study to test whether sequential therapy of… read more here.
Keywords: sclerotic chronic; treatment; sequential treatment; host disease ... See more keywords
Hedgehog blockade in steroid‐refractory sclerotic chronic graft‐versus‐host disease
Sign Up to like & getrecommendations! Published in 2021 at "British Journal of Haematology"
DOI: 10.1111/bjh.17657
Abstract: Sclerotic chronic graft-versus-host disease (ScGVHD) is among the most difficult to treat disease forms affecting increasing number of allogeneic haematopoietic cell transplant survivors. A profibrotic activity of Hedgehog (Hh) signalling has been described in patients… read more here.
Keywords: sclerotic chronic; disease; scgvhd; chronic graft ... See more keywords